Monday, January 19, 2026
HomeIndustriesBiotechnology

Biotechnology

Provention Bio Announces the Grant of Inducement Awards

Provention Bio, Inc, a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, announced that the Company granted stock options to 8 non-executive employees...

Beyond Ionomers: Regulation Drives Demand for New Fuel Cell Membranes, Finds IDTechEx Research

Membrane materials are of fundamental importance for fuel cells. So significant, in fact, that they typically give their name to the fuel cell, as...

Egret Therapeutics Receives FDA Clearance of IND Application for EGT 101 for Treatment of Delayed Cerebral Ischemia

Egret Therapeutics, a clinical-stage biotechnology company focused on developing transformative therapies for neurological conditions, announced that the U.S. Food and Drug Administration (FDA) has...

Rigel Announces Publication of REZLIDHIA™ Phase 2 Clinical Results in Blood Advances

Rigel Pharmaceuticals, Inc.  announced a peer-reviewed publication of data in Blood Advances, which summarizes clinical results from the Phase 2 registrational study of REZLIDHIA™, a...

Read Magazine’s Weekly Roundup Featuring Summit 7, Venterra, Nexar and More!

Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
0FansLike
0FollowersFollow
spot_img

Hot Topics